NCT01386086View on ClinicalTrials.gov

Aripiprazole and Resistant Postpartum Depression

PHASE3CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Postpartum Depression

Interventions

DRUG

aripiprazole

The starting dose of aripiprazole will be 2 mg and the dose adjusted to a maximum of 15 daily

Trial Locations (1)

N6A4H1

Regional Mental Health Care, London

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER